44. 多発血管炎性肉芽腫症 Wegener granulomatosis Clinical trials / Disease details

臨床試験数 : 98 / 薬物数 : 108 - (DrugBank : 28) / 標的遺伝子数 : 22 - 標的パスウェイ数 : 81

6 trials found

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04871191 (ClinicalTrials.gov)	March 2023	26/2/2021	Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis	Salvage Therapy for Patients With Inadequate Response to Standard of Care Therapy in Granulomatosis ...	Granulomatosis With Polyangiitis;Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis	Drug: Rituximab;Drug: Tocilizumab;Drug: Abatacept	Assistance Publique - Hôpitaux de Paris	URC-CIC Paris Descartes Necker Cochin	Not yet recruiting	18 Years	N/A	All	42	Phase 2	France
2	EUCTR2021-000679-35-FR (EUCTR)	07/09/2021	25/06/2021	SATELITE Salvage Therapy for Patients with Inadequate Response to Standard of Care Therapy in Granul ...	SATELITE Salvage Therapy for Patients with Inadequate Response to Standard of Care Therapy in Granul ...	Granulomatosis with Polyangiitis;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15] ...	Trade Name: Rituximab INN or Proposed INN: RITUXIMAB Trade Name: ROACTEMRA INN or Proposed INN: TOCILIZ ...	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	42	Phase 2	France
3	EUCTR2013-005535-24-GB (EUCTR)	07/06/2016	03/12/2015	Abatacept(CTLA4-Ig) for the Treatment of Relapsing, Non-Severe, Granulomatosis with Polyangiitis (We ...	Abatacept(CTLA4-Ig) for the treatment of relapsing, non-severe, granulomatosis with polyangiitis (We ...	Granulomatosis with polyangiitis (GPA; Wegener's granulomatosis) MedDRA version: 19.0;Level: LLT;Cla ...	Trade Name: Orencia Product Name: Abatacept INN or Proposed INN: Abatacept	Univeristy of South Florida	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 3	United States;France;Mexico;Canada;Spain;Ireland;Australia;Germany;Switzerland;Italy;United Kingdom; ...
4	EUCTR2013-005535-24-IE (EUCTR)	04/05/2016	11/02/2016	Abatacept(CTLA4-Ig) for the Treatment of Relapsing, Non Severe, Granulomatosis with Polyangiitis (We ...	Abatacept(CTLA4-Ig) for the Treatment of Relapsing, Non Severe, Granulomatosis with Polyangiitis (We ...	Relapsing, Non Severe, Granulomatosis with Polyangiitis (Wegener’s) MedDRA version: 20.0;Level: LLT; ...	Trade Name: Orencia Product Name: Abatacept (CTLA4-Ig) INN or Proposed INN: ABATACEPT	University of South Florida	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	66	Phase 3	United States;Spain;Ireland;Italy;Switzerland;United Kingdom;France;Mexico;Canada;Belgium;Australia; ...
5	NCT02108860 (ClinicalTrials.gov)	April 25, 2015	27/3/2014	Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)	Abatacept(CTLA4-Ig) for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (We ...	Granulomatosis With Polyangiitis (Wegener's);Granulomatosis With Polyangiitis;Wegener's Granulomatos ...	Drug: Abatacept;Drug: placebo	University of South Florida	The Cleveland Clinic;Bristol-Myers Squibb;University of Pennsylvania;National Institutes of Health ( ...	Active, not recruiting	15 Years	N/A	All	65	Phase 3	United States;Canada;Germany;Ireland;United Kingdom
6	EUCTR2013-005535-24-DE (EUCTR)		18/08/2017	Abatacept(CTLA4-Ig) for the Treatment of Relapsing, Non Severe, Granulomatosis with Polyangiitis (We ...	Abatacept(CTLA4-Ig) for the Treatment of Relapsing, Non Severe, Granulomatosis with Polyangiitis (We ...	Relapsing, Non Severe, Granulomatosis with Polyangiitis (Wegener’s) MedDRA version: 20.0;Level: LLT; ...	Trade Name: Orencia Product Name: Abatacept (CTLA4-Ig)	University of South Florida	NULL	NA			Female: yes Male: yes	150	Phase 3	United States;Spain;Ireland;Switzerland;United Kingdom;Italy;France;Mexico;Canada;Belgium;Australia; ...

First Previous1Next Last